Greenlight Biosciences

company

Number of Lead Investors

Number of Investors

Greenlight Biosciences is funded by 34 investors. Morningside Venture Partners and Khosla Ventures are the most recent investors.

Investor Name	Lead Investor	Funding Round
Morningside Venture Partners	Yes	Series D
Khosla Ventures	Yes	Series A
BNP Paribas Asset Management	-	Post-IPO Equity
Continental Grain Company	-	Post-IPO Equity
Cormorant Asset Management	-	Post-IPO Equity
Cummings Foundation	-	Post-IPO Equity
Fall Line Capital	-	Post-IPO Equity
FTX Foundation	-	Post-IPO Equity
Insud Pharma	-	Post-IPO Equity
Morningside Venture Investments	-	Post-IPO Equity
Rivas Capital	-	Post-IPO Equity
S2G Ventures	-	Post-IPO Equity
Sigmas Group	-	Post-IPO Equity
Symbiosis Group	-	Post-IPO Equity
Hudson Bay Capital Management	-	Post-IPO Equity
Jeremy and Hannelore Grantham Environmental Trust	-	Post-IPO Equity
MLS Capital Fund II	-	Post-IPO Equity
Pura Vida Investments	-	Post-IPO Equity
Serum Life Sciences	-	Post-IPO Equity
Spruce Capital Partners	-	Post-IPO Equity
Viceroy Ventures	-	Post-IPO Equity
Xeraya Capital	-	Post-IPO Equity
AgFunder	-	Series D
Baird Capital	-	Series D
Lewis & Clark Ventures	-	Series D
Lupa Systems	-	Series D
Tao Capital Partners	-	Series D
Flu Lab	-	Series Unknown
Alexandria Venture Investments	-	Series Unknown
Blue I/O	-	Series Unknown
Prelude Ventures	-	Series Unknown
TechAccel	-	Series Unknown
Kodiak Venture Partners	-	Series D
Syngenta Ventures	-	Series D